Literature DB >> 33422410

Systemic Immunoregulatory Consequences of Gut Commensal Translocation.

Alex C McPherson1, Surya P Pandey2, Mackenzie J Bender2, Marlies Meisel3.   

Abstract

One major determinant of systemic immunity during homeostasis and in certain complex multifactorial diseases (e.g. cancer and autoimmune conditions), is the gut microbiota. These commensals can shape systemic immune responses via translocation of metabolites, microbial cell wall components, and viable microbes. In the last few years, bacterial translocation has revealed itself as playing a key, and potentially causal role in mediating immunomodulatory processes in nongastrointestinal diseases. Moreover, recent observations regarding the presence of complex microbial communities and viable bacteria within gut-distal tissues during homeostasis challenge the current paradigm that healthy mammals are entirely sterile at nonmucosal sites. This review discusses our current understanding of how the gut microbiota orchestrates systemic immunity during noninfectious extraintestinal diseases and homeostasis, focusing on the translocation of viable bacteria to gut-distal sites. Published by Elsevier Ltd.

Entities:  

Keywords:  bacterial translocation; disease; health; systemic immunity

Mesh:

Year:  2021        PMID: 33422410     DOI: 10.1016/j.it.2020.12.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  9 in total

1.  Within-host evolution of a gut pathobiont facilitates liver translocation.

Authors:  Yi Yang; Mytien Nguyen; Varnica Khetrapal; Nicole D Sonnert; Anjelica L Martin; Haiwei Chen; Martin A Kriegel; Noah W Palm
Journal:  Nature       Date:  2022-07-13       Impact factor: 69.504

Review 2.  The role of the gut microbiota in multiple sclerosis.

Authors:  Jorge Correale; Reinhard Hohlfeld; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2022-08-05       Impact factor: 44.711

Review 3.  Role of Gut Microbiota in Pulmonary Arterial Hypertension.

Authors:  Panyun Wu; Tengteng Zhu; Zhen Tan; Shenglan Chen; Zhenfei Fang
Journal:  Front Cell Infect Microbiol       Date:  2022-05-06       Impact factor: 6.073

4.  Identification of Gut Bacteria such as Lactobacillus johnsonii that Disseminate to Systemic Tissues of Wild Type and MyD88-/- Mice.

Authors:  Sreeram Udayan; Panagiota Stamou; Fiona Crispie; Ana Hickey; Alexandria N Floyd; Chyi-Song Hsieh; Paul D Cotter; Orla O'Sullivan; Silvia Melgar; Paul W O'Toole; Rodney D Newberry; Valerio Rossini; Ken Nally
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 5.  The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?

Authors:  Jiayao Ma; Lingjuan Huang; Die Hu; Shan Zeng; Ying Han; Hong Shen
Journal:  J Exp Clin Cancer Res       Date:  2021-10-16

6.  Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota.

Authors:  Shuying He; Shudan Cui; Wen Song; Yonghong Jiang; Hongsheng Chen; Dongjiang Liao; Xinpeng Lu; Jun Li; Xueqing Chen; Liang Peng
Journal:  mBio       Date:  2022-03-10       Impact factor: 7.786

7.  Gut Microflora Modulates Th17/Treg Cell Differentiation in Experimental Autoimmune Prostatitis via the Short-Chain Fatty Acid Propionate.

Authors:  He-Xi Du; Shao-Yu Yue; Di Niu; Chang Liu; Li-Gang Zhang; Jing Chen; Yang Chen; Yu Guan; Xiao-Liang Hua; Chun Li; Xian-Guo Chen; Li Zhang; Chao-Zhao Liang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

8.  Characterization of Bacterial Differences Induced by Cleft-Palate-Related Spatial Heterogeneity.

Authors:  Fangjie Zhou; Zhifei Su; Qinyang Li; Renke Wang; Ying Liao; Min Zhang; Jiyao Li
Journal:  Pathogens       Date:  2022-07-05

9.  Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro.

Authors:  Carlos Muñoz; Josue González-Lorca; Mick Parra; Sarita Soto; Natalia Valdes; Ana María Sandino; Rodrigo Vargas; Alex González; Mario Tello
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.